Time New York: Tue 19 Jun 06:10 am  |  Save 15% on H&R Block Online


DENTSPLY (XRAY) Q2 Earnings Miss Estimates, Sales Fall Y/Y


DENTSPLY SIRONA Inc. XRAY is one of the leading worldwide manufacturers’ dental consumables, dental laboratory products, dental specialty products and consumable medical device products. Post DENTSPLY-SIRONA merger, the business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.

Currently, this York, PA- based company carries a Zacks Rank #3 (Hold) but that could change following its second quarter 2017 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank stocks here.) We have highlighted some of the key details from the just-released announcement below:

Earnings: DENTSPLY reported adjusted earnings of 65 cents per share, which missed the Zacks Consensus Estimate by a penny and was lower than earnings of 76 cents in the year-ago quarter.

Revenues: DENTSPLY’s net sales decreased to $992.7 million from $1,022.0 million in the year-ago period. This also came below the Zacks Consensus Estimate of $1,004.0 million. Sales of the combined businesses fell 2.2% at constant currency (cc) basis.

Key Stats: Dental and Healthcare Consumables sales rose 3.0% year over year at cc, while Technologies fell 5.6% in the quarter.

Major Factors: U.S. business in the second quarter was negatively impacted by inventory reduction related to a change in distribution strategy in North America and lower equipment sales to end-users. The company expects adjusted EPS for full year 2017 in the range of $2.65 to $2.75 per diluted share.

Check back later for our full write up on this DENTSPLY earnings report later!

More Stock News: Tech Opportunity Worth $386 Billion in 2017

From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.

Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.